Literature DB >> 12480307

Bacterial ghosts as vaccine candidates for veterinary applications.

Katri Jalava1, Andreas Hensel, Michael Szostak, Stephanie Resch, Werner Lubitz.   

Abstract

The application of new strategies to develop effective vaccines is essential in modern veterinary medicine. The bacterial ghost system is a novel vaccine delivery system endowed with intrinsic adjuvant properties. Bacterial ghosts are nonliving Gram-negative bacterial cell envelopes devoid of cytoplasmic contents while maintaining their cellular morphology and native surface antigenic structures including bioadhesive properties. They are produced by PhiX174 protein E-mediated lysis of Gram-negative bacteria. The intrinsic adjuvant properties of bacterial ghost preparations enhance immune responses against envelope bound antigens, including T-cell activation and mucosal immunity. Since native and foreign antigens can be expressed in the envelope complex of ghosts before E-mediated lysis, multiple antigens of various origins can be presented to the immune system simultaneously. The advantages of bacterial ghosts include the simplicity of the production method, safety, independence from the cold chain, and versatility as a combination vaccine.

Mesh:

Substances:

Year:  2002        PMID: 12480307     DOI: 10.1016/s0168-3659(02)00267-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  23 in total

1.  Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge.

Authors:  Ulrike Beate Mayr; Christoph Haller; Wolfgang Haidinger; Alena Atrasheuskaya; Eugenij Bukin; Werner Lubitz; Georgy Ignatyev
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Purification and functional characterization of phiX174 lysis protein E.

Authors:  Yi Zheng; Douglas K Struck; Ry Young
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

3.  Plackett-Burman randomization method for Bacterial Ghosts preparation form E. coli JM109.

Authors:  Amara A Amro; Mounir M Salem-Bekhit; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2013-06-24       Impact factor: 4.330

Review 4.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

5.  Protective efficacy by various doses of Salmonella ghost vaccine candidate carrying enterotoxigenic Escherichia coli fimbrial antigen against neonatal piglet colibacillosis.

Authors:  Jin Hur; John Hwa Lee
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

6.  Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.

Authors:  Chetan V Jawale; Atul A Chaudhari; Byung Woo Jeon; Rahul M Nandre; John Hwa Lee
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

7.  Functional display of ice nucleation protein InaZ on the surface of bacterial ghosts.

Authors:  Johannes Kassmannhuber; Mascha Rauscher; Lea Schöner; Angela Witte; Werner Lubitz
Journal:  Bioengineered       Date:  2017-01-25       Impact factor: 3.269

8.  Generation of Salmonella ghost cells expressing fimbrial antigens of enterotoxigenic Escherichia coli and evaluation of their antigenicity in a murine model.

Authors:  Chan Song Kim; Jin Hur; Seong Kug Eo; Sang-Youel Park; John Hwa Lee
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

9.  Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.

Authors:  Chetan V Jawale; John Hwa Lee
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

10.  Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens.

Authors:  Atul A Chaudhari; Chetan V Jawale; Sam Woong Kim; John Hwa Lee
Journal:  Vet Res       Date:  2012-05-23       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.